Proof that Mycobacterium Abscessus Doesn’t Always Lead to Transplant Failure
Part two of a series. Read part one. Last week, I wrote about how disheartened I felt that many lung transplant centers refuse to help...


Award granted to Neem Biotech to develop antimicrobial intervention for chronic lung infections
Neem Biotech, a Wales based R&D pharmaceutical biotech working in the field of novel antimicrobial drug development, is pleased to...


#ECFS2018 – AB-PA01, with Antibiotics, Shows Promise in Treating Drug-resistant Lung Infections in C
AmpliPhi Biosciences’ investigative therapy AB-PA01, in combination with antibiotics, shows significant potential to treat multi-drug...


Way Found to Use Antimicrobial Peptides, Part of Immune System, to Treat Bacterial Lung and Wound In
Antimicrobial peptides administered as tiny nanoparticles show promise in treating bacterial infections without risking making the...


Celtaxsys Announces Last Patient, Last Visit in Landmark CF Phase 2b Lung Function Preservation Tria
ATLANTA, May 17, 2018 (GLOBE NEWSWIRE) -- Celtaxsys, Inc., a clinical stage pharmaceutical development company focused on advancing...

Gastrointestinal Cancers More Common in Adults with CF, Especially After Transplant, Study Finds
Patients with cystic fibrosis (CF) are at higher-than-average risk of developing gastrointestinal cancers, especially those who underwent...


Improving Antibiotic Strategies To Combat Respiratory Infections In Cystic Fibrosis Patients
Cystic fibrosis (CF) is an inherited, progressive disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR)...

Myoepithelial Cells Are Reserve Stem Cells For Lung Airway Repair
A new population of stem cells that appear to be important for regenerating the airway following severe injury has been identified by...


Lung Stem Cells Discovery in Mice May Benefit Cystic Fibrosis Treatment
A new population of lung stem cells capable of repairing the airways following a severe injury was identified in two preclinical studies....


Lying Instead of Sitting During CF Inhalation Therapy Doesn’t Increase Delivery Time, Study Finds
It takes only slightly longer to deliver an inhaled therapy in cystic fibrosis (CF) patients sitting upright than when lying alternately...

